Figure 1.ai

figure

posted on 2024-10-22, 09:38 authored by Kouki NioKouki Nio

VEGFR2-targeted therapy suppresses the progression of AFP-positive hepatocellular carcinoma after combination therapy with anti-PD-L1 and anti-VEGF-A antibodies

History

Usage metrics

Categories

Keywords

hepatocellular carcinoma cancer stem cell VEGFR2-targeted therapy cancer immunotherapy tumor microenvironment

Licence

Exports